S-1在胃癌中的研究进展

被引：20

作者：

张煜

马力文

机构：

[1] 北京大学第三医院肿瘤治疗中心

来源：

癌症进展 | 2010年 / 8卷 / 02期

关键词：

胃癌; 化疗; S-1;

D O I：

暂无

中图分类号：

R735.2 [胃肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>目前胃癌的治疗方法主要包括手术、化疗、放疗及靶向治疗,尚无统一的标准策略及治疗方案。对于可手术切除的胃癌患者,美国依据INT0116试验制定了胃癌根治性手术联合术后同步放化疗的方案,而同时日本却认为胃癌根治术后行辅助化疗为最佳方案。虽然公认化疗可使晚期胃癌获益,但是

引用

页码：148 / 150

页数：3

共 8 条

[1]

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial [J].

Koizumi, Wasaburo ;

Narahara, Hiroyuki ;

Hara, Takuo ;

Takagane, Akinori ;

Akiya, Toshikazu ;

Takagi, Masakazu ;

Miyashita, Kosei ;

Nishizaki, Takashi ;

Kobayashi, Osamu ;

Takiyama, Wataru ;

Toh, Yasushi ;

Nagaie, Takashi ;

Takagi, Seiichi ;

Yamamura, Yoshitaka ;

Yanaoka, Kimihiko ;

Orita, Hiroyuki ;

Takeuchi, Masahiro .

LANCET ONCOLOGY, 2008, 9 (03) :215-221

[2]

A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer [J].

Nakajo, Akihiro ;

Hokita, Shuichi ;

Ishigami, Sumiya ;

Miyazono, Futoshi ;

Etoh, Tadaaki ;

Hamanoue, Masahiro ;

Maenohara, Shigeho ;

Iwashita, Toshimitsu ;

Komatsu, Hideaki ;

Satoh, Kiyoharu ;

Aridome, Kuniaki ;

Morita, Satoshi ;

Natsugoe, Shoji ;

Takiuchi, Hiroya ;

Nakano, Shyuji ;

Maehara, Yoshihiko ;

Sakamoto, Junichi ;

Aikou, Takashi ;

Taxol, Kyushu .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) :1103-1109

[3]

Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients [J].

Yamanaka, Takeharu ;

Matsumoto, Shigemi ;

Teramukai, Satoshi ;

Ishiwata, Ryota ;

Nagai, Yoji ;

Fukushima, Masanori .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) :335-343

[4]

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer [J].

Lee, Jae-Lyun ;

Kang, Hye Jin ;

Kang, Yoon-Koo ;

Ryu, Min-Hee ;

Chang, Heung Moon ;

Kim, Tae-Won ;

Sohn, Hee Jung ;

Kim, Hawk ;

Lee, Jung Shin .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) :837-845

[5]

Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer [J].

Kochi, Mitsugu ;

Fujii, Masashi ;

Kanamori, Noriaki ;

Kaiga, Teruo ;

Takahashi, Toru ;

Kobayashi, Michiyo ;

Takayama, Tadatoshi .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (12) :781-785

[6]

Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination [J].

Satoh S. ;

Hasegawa S. ;

Ozaki N. ;

Okabe H. ;

Watanabe G. ;

Nagayama S. ;

Fukushima M. ;

Takabayashi A. ;

Sakai Y. .

Gastric Cancer, 2006, 9 (2) :129-135

[7]

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer [J].

Michiya Kobayashi ;

Akira Tsuburaya ;

Naoki Nagata ;

Yumi Miyashita ;

Koji Oba ;

Junichi Sakamoto .

Gastric Cancer, 2006, 9 (2) :114-119

[8]

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators [J].

Shirasaka, T ;

Shimamato, Y ;

Ohshimo, H ;

Yamaguchi, M ;

Kato, T ;

Yonekura, K ;

Fukushima, M .

ANTI-CANCER DRUGS, 1996, 7 (05) :548-557

← 1 →